The distribution of myeloid-derived suppressor cells subsets and up-regulation of programmed death-1/PD-L1 axis in peripheral blood of adult CAP patients

PLoS One. 2023 Sep 27;18(9):e0291455. doi: 10.1371/journal.pone.0291455. eCollection 2023.

Abstract

Background: Myeloid-derived suppressor cells (MDSCs) have been reported to expand and have a potent ability in the expansion of regulatory T cells in malignant and infectious disease. The current study was performed to investigate the role of MDSCs and possible immune mechanisms in dampening immune responses of community acquired pneumonia (CAP).

Methods: This was a single-center cross-sectional study. The distribution of MDSCs subsets, the PD-1/PD-L1(L2) level of MDSCs subsets and Tregs in the peripheral blood of adult CAP patients and healthy control were measured by flow cytometry analysis.

Results: Peripheral blood mononuclear cells (PBMCs) from 63 adult CAP patients contained an elevated frequency of both G-MDSC (4.92±0.30 vs 2.25±0.21,p<0.0001) and M-MDSC (19.40±1.30 vs 9.64±0.57,p<0.001) compared to healthy controls. Treg in the peripheral blood of CAP patients exhibited increased expression of PD-1 and CTLA-4, accompanied by no difference of their frequency. Moreover, up-regulated expression of PD-L1 on MDSC subsets in the peripheral blood of CAP patients was also revealed. Of note, the frequency of circulating MDSCs subset displayed a positive correlation with neutrophil count percentage in blood in CAP patients.

Conclusions: In summary, the significant expansion of circulating MDSCs subsets and the up-regulated expression of PD-1/PD-L1 level in CAP patients may suggest the possible involvement of PD-1/PD-L1axis in MDSCs mediated immune regulation on Treg at least partially in CAP patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • B7-H1 Antigen
  • Community-Acquired Infections*
  • Cross-Sectional Studies
  • Humans
  • Leukocytes, Mononuclear
  • Myeloid-Derived Suppressor Cells*
  • Pneumonia*
  • Programmed Cell Death 1 Receptor
  • Up-Regulation

Substances

  • B7-H1 Antigen
  • Programmed Cell Death 1 Receptor

Grants and funding

National Natural Science Foundation of China(No.82000048 and No.81900021) and Beijing Clinical Key Specialty (grant No. XKB2022B1002) in the “Funding information”section of the online submission form. And our response to “Financial Disclosure” should be revised as follows:“This study was supported by the National Natural Science Foundation of China (No.82000048 and No.81900021) and Beijing Clinical Key Specialty (grant No.XKB2022B1002), the fund recipients are Haihong Gong(No.82000048) and Mingqiang Zhang(No.81900021 and No.XKB2022B1002) respectively.